EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC-ND 4.0

Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”

Alzheimer's & Dementia · 2026-04 · 22 (4)

DOI: 10.1002/alz.71347 ↗

Kurz gefasst

Korrektur in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.04.2026. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”. Alzheimer's & Dementia, 22(4). https://doi.org/10.1002/alz.71347

Vancouver

Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”. Alzheimer's & Dementia. 2026;22(4). doi:10.1002/alz.71347

BibTeX
@article{euvimed2026,
  title = {Correction to “Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: A multicenter real‐world study”},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {4},
  doi = {10.1002/alz.71347}
}
Kostenlos starten →